All In Biotech

Free tool

FAERS Monitor: Advil Allergy and Congestion Relief

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022113 or its brand name (Advil Allergy and Congestion Relief, Chlorpheniramine Maleate, Ibuprofen, Phenylephrine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

576

Serious

31

5% of reports

Hospitalization

9

Death reported

1

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective179
  • product use in unapproved indication99
  • drug effective for unapproved indication89
  • somnolence50
  • feeling abnormal28
  • drug effect incomplete18
  • therapeutic product effect incomplete18
  • dizziness17
  • therapeutic response unexpected16
  • dyspnoea15
  • fatigue14
  • incorrect dose administered14
  • abdominal pain upper11
  • condition aggravated11
  • malaise11

Reports by year received

View as table
YearReports
20126
201344
201452
2015114
201641
201717
201817
201934
202041
202144
202285
202359
202413
20256
20263

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,583 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug effective for unapproved indicationSignal89111.391.99,601
drug effect incompleteSignal1818.111.5274
product use in unapproved indicationSignal9914.612.21,254
therapeutic response unexpectedSignal1613.08.0166
therapeutic product effect incompleteSignal189.25.9125
somnolenceSignal509.17.0354
drug ineffectiveSignal1795.04.4599
feeling abnormalSignal284.33.068
incorrect dose administeredSignal142.21.38
abdominal pain upper112.01.14
condition aggravated111.30.71
dizziness171.20.81
dyspnoea151.00.60
malaise110.90.50
fatigue140.70.42

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.